Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-09-13
2005-09-13
Spector, Lorraine (Department: 1647)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007200, C435S007210, C436S501000
Reexamination Certificate
active
06942982
ABSTRACT:
The present invention relates to novel compounds and their pharmaceutical or diagnostic use, or use as a pharmacological target. More particularly, the present invention describes the identification of partners of the FE65 protein and the use of these partners, or of any compound which is capable of modulating, at least partially, their interaction with FE65, for regulating the activity of FE65, and in particular the phenomenon of intracellular transport or of endocytosis of the APP.
REFERENCES:
patent: 5389526 (1995-02-01), Slade et al.
patent: 5928882 (1999-07-01), Sabo et al.
patent: 6214582 (2001-04-01), Marcu
patent: WO 99/26961 (1999-06-01), None
Zambrano et al. (Mar. 7, 1997) “Interaction of the Phosphotyrosine Interaction/Phosphotyrosine Binding-related Domains of Fe65 with Wild-type and Mutant Alzheimer's b-Amyloid Precursor Protein.” The Journal of Biological Chemistry 272(10): 6399-6405.
Bradford Chemical Neurobiology: An Introduction to Neurochemistry (1986) Chapter 9 W.H. Freeman and Company, New York.
Voet & Voet Biochemistry 2ndEd. (1995) Chapter 13 John Wiley & Sons, Inc. New York.
Lam & Breakefield (2000) Hybrid Vetror Designs to Control the Delivery, Fate, and Expression of Transgenes. J Gene Med 2:395-408.
Kochanek et al. (2001) High-Capacity ‘Gutless’ Adenoviral Vectors. Current Opinion in Molecular Therapeutics. 3(5): 454-463.
Skolnick & Fetrow (2000) From Genes to Protein Structure and Function: Novel Applications of Computational Approaches in the Genomic Era. Trends in Biotech 18(1):34-39.
Bork (2000) Powers and Pitfalls in Sequence Analysis: The 70% Hurdle. Genome Research 10:398-400.
Doerks (1998) Protein Annotation: Dectective Work for Function Prediction. TIG 14(6): 248-250.
Bork (1996) Go Hunting in Sequence Databases but Watch out for Traps. TIG 12(10): 425-427.
Friedmann (1992) Gene Therapy of Cancer Through Restoration of Tumor-Suppressor Functions? Cancer 70:1810-1817.
Brenner (1999) Errors in Genome Annotation. TIG 15(4): 132-133.
Smith & Zhang (1997) The Challenges of Genome Sequence Annotation or “The Devil is in the Details”. Nature Biotechnology 15: 1222-1223.
Anderson (1984) Prospects for Human Gene Therapy. Science 226: 401-409.
Gutierrez et al. (1992) Gene Therapy for Cancer. The Lancet 339: 715-721.
Verma and Somia (1997) Gene Therapy—Promises, Problems, and Prospects. Nature 389: 239-241.
Goodman & Gilman's The Pharmacological Basis of Therapeutics 9thEd. (1996) McGraw-Hill New York Chapter 5: Gene-Based Therapy by Eck & Wilson.
Pinol-Roma et al, A novel heterogenous nuclear RNP protein with a unique distribution on nascent transcripts., J. Cell. Biol. 109: 2575-2587 (1989).
Rasmussen et al, Microsequences of 145 proteins recorded in the two-dimensional gel protein database of normal epidermal keratinocytes, Electrophoresis 13:960-969 (1992).
Zambrano et al, The Fe65 adaptor protein interacts through its PID1 domain with the transcription factor CP2/LSF/LBP1, J. Biol. Chem. 273/32 (20128-20133) (1998).
McLoughlin et al, The intracellular cytoplasmic domain of the Alzheimer's disease amyloid precursor protein interacts with phosphotyrosine-binding domain proteins in the yeast two-hybrid system., FEBS Letters (1996) 397/2-3 (197-200).
Fiore et al, The regions of the Fe65 protein homologous to the phosphotyrosine interaction phosphotyrosine binding domain of Shc bind the intracellular domain of Alzheimer's amyloid precursor protein, J. Biol. Chem. 270(53):30853-30856 (1995).
Borg et al, The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein, Molec. and Cell. Biol. 16(11):6229-6241 (1996).
English Translation of Borg et al.,PTB, An Important Protein-Protein Interaction Domain of the“domino effect”of Signal TransductionMedecine/Sciences 13:647-656 (1997).
Fournier Alain
Maury Isabelle
Mercken Luc
Aventis Pharma S.A.
Nichols Christopher James
Spector Lorraine
LandOfFree
FEBP1 protein vector host cells and method for making FEBP1... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with FEBP1 protein vector host cells and method for making FEBP1..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and FEBP1 protein vector host cells and method for making FEBP1... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3422910